Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories Announces New $3 Billion Share Repurchase Program; Declares Dividend

Friday, 14 Jun 2013 12:22pm EDT 

Abbott Laboratories announced that its board of directors has approved a new share repurchase program and declared a quarterly common dividend. Abbott's board has authorized the repurchase of up to $3 billion of the corporation's common stock. The program replaces the previous $5 billion program that was announced in October 2008 and was recently completed. The purchases may be made from time to time as market conditions warrant and subject to regulatory considerations. The board also declared a quarterly common dividend of $0.14 per share. The cash dividend is payable August 15, 2013, to shareholders of record at the close of business on July 15, 2013. 

Latest Key Developments inPharmaceuticals

Company Quote

0.38 +0.82%
20 Apr 2015